WALTHAM, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC) today announced that company management will present at the following investor conferences in November: Event:Piper Sandler 34th Annual Healthcare ConferenceDate:November 29 – December 1, 2022Location:Lotte New York Palace in New York, New YorkPresentation:Tuesday, November 29, 2022 at 1:30pm ESTWebcast:https://event.webcasts.com/starthere.jsp?ei=1585686&tp_key=3261cabcd6 Event:Evercore ISI 5th Annual HealthCONx ConferenceDate:November 30 – December 1, 2022Location:VirtualPresentation:Thursday, December 1, 2022 at 3:30pm ESTWebcast:https://wsw.com/webcast/evercore29/cinc/2336910 The CinCor management team will participate in one-on-one investor meetings during these events. Investors interested in meeting with CinCor at the conference should contact their Piper Sandler or Evercore ISI representative. An archived replay of the presentations will be available for 90 days at CinCor.com/events. About CinCorCinCor, founded in 2018, is a clinical-stage biopharmaceutical company with a mission to bring innovation to the pharmaceutical treatment of cardio-renal diseases. Its lead asset, baxdrostat, a highly selective, oral small molecule inhibitor of aldosterone synthase, is in clinical development for the treatment of hypertension and primary aldosteronism. Contacts: Investors:Michael KalbBob YedidCinCor Pharma, Inc.LifeSci AdvisorsEVP and CFO ir@CinCor.com